Find a specific notice:
Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Publication Date
10 Aug 2017

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2017-go4063

Issue Number

80
Title
View PDF
File Type and Size
PDF (21 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Atropine Sulphate Injection
Atropine sulfate 0.06%w/v
Solution for injection
Max Health Limited
Macarthys Laboratories Limited t/a Martindale Pharmaceuticals, London, United Kingdom

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Xolair
Omalizumab 150mg/mL
Solution for injection
Novartis New Zealand Limited
Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Xolair
Omalizumab 75mg/0.5mL
Solution for injection
Novartis New Zealand Limited
Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany


Dated this 3rd day of August 2017.

ALISON COSSAR, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).